| | | | | | | |
 | CSL LIMITED | -0.69% | -0.09% | 5.71% | 13.07% | 5.62% | 95 414 |
 | BIOGEN INC. | 0.51% | -3.18% | 7.85% | 44.84% | -0.93% | 43 229 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -0.26% | -1.27% | -5.36% | -6.83% | 24.52% | 41 685 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -3.16% | -1.49% | -28.24% | -20.90% | 3.49% | 23 189 |
 | UCB | 1.24% | -5.87% | 12.97% | 0.34% | -4.24% | 16 863 |
| BIOMARIN PHARMACEUTICAL INC. | -0.28% | -3.72% | -14.50% | 9.28% | -17.07% | 16 609 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | 0.27% | -1.78% | -16.91% | -13.84% | -10.79% | 16 526 |
| INCYTE CORPORATION | -0.46% | -1.19% | -22.09% | -18.93% | -36.29% | 13 961 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | -2.40% | -3.80% | -24.91% | -30.09% | 203.05% | 12 200 |
| APELLIS PHARMACEUTICALS, INC. | 2.14% | -2.13% | 68.19% | 104.11% | 151.07% | 10 128 |
| CELLTRION HEALTHCARE CO., LTD. | 0.14% | -2.90% | 27.07% | 26.27% | -8.76% | 8 938 |
| INNOVENT BIOLOGICS, INC. | -4.79% | -0.40% | 12.69% | 73.17% | -10.65% | 7 401 |
 | GRIFOLS, S.A. | 1.48% | -1.48% | 5.34% | -42.85% | -59.48% | 7 345 |
| AIM VACCINE CO., LTD. | -1.68% | -7.98% | 84.03% | --.--% | --.--% | 6 771 |
| WALVAX BIOTECHNOLOGY CO., LTD. | 1.39% | -1.13% | -25.70% | -37.66% | -29.69% | 6 767 |
| | | | | | | |
| | Durchschnitt | -0.44% | -2.56% | 5.74% | 7.14% | 14.99% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.45% | -1.86% | 1.69% | 9.30% | 11.78% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
